Skip to main content

Table 3 Sensitivity for detection of methylated TRIM9 in plasma of Stage IV and metastatic breast cancer patients

From: Promoter methylation of TRIM9 as a marker for detection of circulating tumor DNA in breast cancer patients

  Total Methylated TRIM9 in plasma
  Positive Negative
No. (%) No. (%)
Healthy control 60 0 (0) 60 (100)
MBC patients (total) 56 10 (18) 46 (82)
MBC patients with TRIM9 hypermethylated tumors 9 4 (44) 5 (56)
MBC patients with TRIM9 hypomethylated tumors 18 1 (6) 17 (94)
  1. MBC metastatic breast cancer